| Literature DB >> 24636355 |
J Enrique Salcedo-Sora1, Eva Caamano-Gutierrez2, Stephen A Ward1, Giancarlo A Biagini3.
Abstract
We hypothesise that intraerythrocytic malaria parasite metabolism is not merely fulfilling the need for ATP generation, but is evolved to support rapid proliferation, similar to that seen in other rapidly proliferating cells such as cancer cells. Deregulated glycolytic activity coupled with impaired mitochondrial metabolism is a metabolic strategy to generate glycolytic intermediates essential for rapid biomass generation for schizogony. Further, we discuss the possibility that Plasmodium metabolism is not only a functional consequence of the 'hard-wired' genome and argue that metabolism may also have a causal role in triggering the cascade of events that leads to developmental stage transitions. This hypothesis offers a framework to rationalise the observations of aerobic glycolysis, atypical mitochondrial metabolism, and metabolic switching in nonproliferating stages.Entities:
Keywords: Warburg effect; dormancy; epigenetics; gametocytes; glycolysis; malaria
Mesh:
Year: 2014 PMID: 24636355 PMCID: PMC3989997 DOI: 10.1016/j.pt.2014.02.001
Source DB: PubMed Journal: Trends Parasitol ISSN: 1471-4922
Figure 1Proliferating cell hypothesis: similarities between cancer cells and Plasmodium falciparum. Principle end products of glucose consumption (lactate, alanine, pyruvate, glycerol-3-phosphate, and glycerol, shown in red boxes) are similar in both cancer cells [3] and asexual intraerythrocytic malaria parasites [12]. A high glycolytic flux maintains rate-limiting glycolytic intermediates to support nucleotide (via glucose-6-phosphate to 5-phosphoribosyl-α-pyrophosphate) and lipid biosynthesis (via dihydroxyacetone phosphate to glycerol-3-phosphate). Metabolic modifications (Boxes 1 and 2) allow aerobic glycolysis/fermentation to proceed rapidly whilst keeping tricarboxylic acid (TCA) flux low. Anapleorotic glutaminolysis follows past part of the TCA cycle through the five-carbon α-ketoglutarate [15]. Subsequent conversion of oxaloacetate to phosphoenolpyruvate (PEP) by phosphoenolpyruvate carboxykinase (PEPCK, EC 4.1.1.49) allows for further synthesis of biosynthetic intermediates (e.g., via shikimate pathway [16] and isoprenoid biosynthesis [17]). Abbreviations: GLUT-1, glucose transporter 1; PfHT1, Plasmodium falciparum hexose transporter 1; HK, hexokinase (EC 2.7.1.1); PGI, phosphoglucose isomerase (EC 5.3.1.9); PFK, phosphofructokinase (EC 2.7.1.11); G3PDH, glyceraldehyde 3 phosphate dehydrogenase (EC 1.2.1.12); PGK, phosphoglycerate kinase (EC 2.7.2.3); PK, pyruvate kinase (EC 2.7.1.40); LDH, lactate dehydrogenase (EC 1.1.1.27); PEPCase, phosphoenolpyruvate carboxylase (EC 4.1.1.31); PC, pyruvate carboxylase (EC 6.4.1.1); PDH, pyruvate dehydrogenase (EC 1.2.4.1); BCKDH, branched chain ketoacid dehydrogenase (EC 1.2.4.4); Suc-CoA, succinyl-CoA.